Boston Scientific: Leerink Partners cuts target price to $55 from $60
BSX•Leerink Partners cut its target price for Boston Scientific to $55 from $60.
Related News
Marriott sets third-quarter earnings release and investor conference call
MAR•
Oil falls as Trump comments on Iran talks ease supply concerns
USO•
3M files initial beneficial ownership statement for CTO Tushar A. Kshirsagar
MMM•
Pilgrim’s Pride forms special committee to review JBS N.V. proposal
PPC•
Copper heads for a weekly gain on mine supply risks, China demand
CPER•